Scott is a Partner at Novo Ventures US and focuses on late stage private and public investments. Scott joined Novo Ventures in 2012. From 2009 through 2012, Scott was a member of Novo A/S’ Growth Equity team. Prior to joining Novo A/S, Scott was a Managing Director at JP Morgan in San Francisco and headed that firm’s west coast biopharmaceuticals effort. Before joining JPM, Scott led Piper Jaffray’s US biopharmaceuticals investment banking practice and was a member of the Health Care Group at Montgomery Securities. Scott holds an MBA from UCLA and a BS from Colorado State University.